Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 9, 2022
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
[ Wed, Mar 09th 2022
] - WOPRAI
Tue, March 8, 2022
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
Jessica Fye Upgraded (CARA) to Buy and Increased Target to $20 on, Mar 8th, 2022
Jessica Fye of JP Morgan, Upgraded "Cara Therapeutics, Inc." (CARA) to Buy and Increased Target from $17 to $20 on, Mar 8th, 2022.
Jessica, nor any peers, have made any analyst calls on CARA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30